Credit Suisse’s Tivity Health, Inc. Common Stock TVTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-33,041
| Closed | -$1.06M | – | 4585 |
|
|
2022
Q1 | $1.06M | Buy |
33,041
+1,355
| +4% | +$36.6K | ﹤0.01% | 2507 |
|
|
2021
Q4 | $838K | Buy |
31,686
+1,405
| +5% | +$35.7K | ﹤0.01% | 3456 |
|
|
2021
Q3 | $699K | Sell |
30,281
-25,693
| -46% | -$610K | ﹤0.01% | 3587 |
|
|
2021
Q2 | $1.47M | Buy |
55,974
+28,337
| +103% | +$712K | ﹤0.01% | 3089 |
|
|
2021
Q1 | $616K | Buy |
27,637
+13,852
| +100% | +$318K | ﹤0.01% | 3635 |
|
|
2020
Q4 | $270K | Buy |
+13,785
| New | +$229K | ﹤0.01% | 4015 |
|
|
2020
Q2 | – | Sell |
-42,885
| Closed | -$270K | – | 4219 |
|
|
2020
Q1 | $270K | Buy |
42,885
+10,973
| +34% | +$177K | ﹤0.01% | 3492 |
|
|
2019
Q4 | $649K | Sell |
31,912
-1,813
| -5% | -$33.9K | ﹤0.01% | 3412 |
|
|
2019
Q3 | $560K | Buy |
33,725
+2,453
| +8% | +$42.4K | ﹤0.01% | 3374 |
|
|
2019
Q2 | $515K | Sell |
31,272
-17,582
| -36% | -$339K | ﹤0.01% | 3383 |
|
|
2019
Q1 | $857K | Buy |
48,854
+5,739
| +13% | +$122K | ﹤0.01% | 3006 |
|
|
2018
Q4 | $1.07M | Buy |
43,115
+11,986
| +39% | +$399K | ﹤0.01% | 2725 |
|
|
2018
Q3 | $1M | Sell |
31,129
-8,018
| -20% | -$274K | ﹤0.01% | 2873 |
|
|
2018
Q2 | $1.38M | Sell |
39,147
-14,701
| -27% | -$543K | ﹤0.01% | 2776 |
|
|
2018
Q1 | $2.14M | Buy |
53,848
+7,649
| +17% | +$297K | ﹤0.01% | 2359 |
|
|
2017
Q4 | $1.69M | Sell |
46,199
-2,622
| -5% | -$99.4K | ﹤0.01% | 2569 |
|
|
2017
Q3 | $1.99M | Buy |
48,821
+14,630
| +43% | +$567K | ﹤0.01% | 2543 |
|
|
2017
Q2 | $1.36M | Sell |
34,191
-13,758
| -29% | -$460K | ﹤0.01% | 2495 |
|
|
2017
Q1 | $1.4M | Buy |
+47,949
| New | +$1.26M | ﹤0.01% | 2620 |
|
|
2016
Q4 | – | Sell |
-50,799
| Closed | -$1.34M | – | 4282 |
|
|
2016
Q3 | $1.34M | Sell |
50,799
-21,738
| -30% | -$439K | ﹤0.01% | 2701 |
|
|
2016
Q2 | $837K | Buy |
72,537
+26,428
| +57% | +$309K | ﹤0.01% | 3075 |
|
|
2016
Q1 | $465K | Buy |
46,109
+12,875
| +39% | +$145K | ﹤0.01% | 3284 |
|
|
2015
Q4 | $428K | Buy |
33,234
+3,091
| +10% | +$37.6K | ﹤0.01% | 3494 |
|
|
2015
Q3 | $336K | Sell |
30,143
-49,497
| -62% | -$605K | ﹤0.01% | 3650 |
|
|
2015
Q2 | $954K | Buy |
79,640
+5,880
| +8% | +$97.6K | ﹤0.01% | 3230 |
|
|
2015
Q1 | $1.45M | Buy |
73,760
+32,112
| +77% | +$672K | ﹤0.01% | 2673 |
|
|
2014
Q4 | $829K | Sell |
41,648
-16,512
| -28% | -$270K | ﹤0.01% | 3307 |
|
|
2014
Q3 | $932K | Buy |
58,160
+19,179
| +49% | +$325K | ﹤0.01% | 3121 |
|
|
2014
Q2 | $683K | Sell |
38,981
-42,825
| -52% | -$735K | ﹤0.01% | 3607 |
|
|
2014
Q1 | $1.4M | Sell |
81,806
-4,947
| -6% | -$76.1K | ﹤0.01% | 2822 |
|
|
2013
Q4 | $1.33M | Sell |
86,753
-22,581
| -21% | -$321K | ﹤0.01% | 3029 |
|
|
2013
Q3 | $2.02M | Buy |
109,334
+80,269
| +276% | +$1.45M | ﹤0.01% | 2377 |
|
|
2013
Q2 | $505K | Buy |
+29,065
| New | +$401K | ﹤0.01% | 3301 |
|
Other funds holding TVTY
BCMLT
PP
IA
Credit Suisse's TVTY Position: Q2 2022 in Review
Credit Suisse sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 33,041 shares — an estimated $1.06M sold.
Credit Suisse first reported a position in TVTY in Q2 2013 and held it in 33 quarters. The position peaked at $2.14M in Q1 2018. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.
- Credit Suisse reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Credit Suisse sold 33,041 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $1.06M.
- Credit Suisse first reported a position in Tivity Health, Inc. Common Stock in Q2 2013 and held it in 33 quarters.
- Credit Suisse's Tivity Health, Inc. Common Stock position peaked at $2.14M in Q1 2018.
- 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.
Based on Credit Suisse's 13F filing for Q2 2022, filed 12 Aug 2022.